[ Fo lkman J. Ang iogenes is in cancer, vascular, rheum a to id and o ther disease[ J]. NatM ed, 1995, 1( 1): 27- 31.
[2]
[ Fe rrara N, H enze lW J. P itu itary fo llicular ce lls secre te a nove l hepar in-b inding grow th factor spec ific for vascular endothe lial ce lls[ J]. B iochem B iophys Res Commun, 1989, 161( 2): 851- 858.
[3]
[ H annon G J. RNA interference[ J]. Nature, 2002, 418( 6894): 244- 251.
[4]
[ Shen C, Buck A K, Liu X, et a .l Gene silenc ing by adenov irus-de livered siRNA[ J]. FEBS Lett, 2003, 539: 111- 114.
[5]
[ Sam brook J, Fritsch E F, M aniatis T. Mo lecu la r C loning[M ]. 2nd ed. Co ld Spr ing H arbor, New Yo rk: Co ld Spring H arbor Labo ra tory Press, 1989.
[6]
[ Annabi B, Thibeault S, Lee Y T, et a.l M atr ix m e tallopro te inase regulation of sph ingosine-1-phosphate- induced ang iogenic properties o f bone m arrow strom al ce lls[ J] . Exp H em ato,l 2003, 31: 640- 649.
[7]
[ Zhang L, Yang N, M oham ed-H adleyA, et a.l Vecto r-based RNA,i a nove l tool fo r iso fom-specific kno ck-down of VEGF and ant-i ang iogenes is g ene therapy of cance r[ J]. B iochem B iophys Res Commun, 2003, 303: 1 169- 1 178.
[8]
[ Re ich S J, Fo sno t J, Kurok iA, et a.l Sm a ll inter fe ring RNA ( siRNA) targetingVEGF effectively inhabits o cu lar neovasculariza tion in a m ousem oda l[ J] . M o lV is, 2003, 9: 210- 216.
